Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burak Bilgin

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Cornea|May 3, 2013
Reply: To PMID 22790186Mustafa Ünal, Osman Sevki Arslan, Burak Bilgin
Optometry and Vision Science : Official Publication of the American Academy of Optometry|March 13, 2013
Treatment of peripheral pigment epithelium iris cyst with SLT laserMete Güler, Burak Bilgin, Ali Hakim Reyhan
European Journal of Ophthalmology|November 21, 2009
Toxic anterior segment syndrome after uncomplicated cataract surgeryN Demet Ozcelik, Kadir Eltutar, Burak Bilgin
Arquivos Brasileiros De Oftalmologia|June 8, 2017
Comparison of optical coherence tomographic findings between Behcet disease patients with and without ocular involvement and healthy subjectsAyse Sevgi Karadag, Burak Bilgin, Merih Banu Soylu
Future Oncology (London, England)|November 25, 2024
What is the ideal treatment for advanced non-small-cell lung cancer with PD-L1 level ≥50%? Is mono immunotherapy enough?Burak Bilgin, Sebnem Yucel, Mehmet Ali Nahit Sendur, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 20, 2010
Conversion to deep anterior lamellar keratoplasty (DALK): learning curve with big-bubble techniqueMustafa Unal, Burak Bilgin, Iclal Yucel, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 3, 2017
Negative CDX2 expression can be an important predictive and prognostic biomarker in stage II colon cancerBurak Bilgin, Mehmet A Sendur, Muhammed B Akinci, et al.
Korean Journal of Ophthalmology : KJO|June 2, 2015
Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injectionMete Güler, Burak Bilgin, Musa Çapkın, et al.
Strabismus|April 18, 2014
The effects of mild-to-severe retinopathy of prematurity on the development of refractive errors and strabismusHuseyin Gursoy, Hikmet Basmak, Burak Bilgin, et al.
Expert Opinion on Biological Therapy|September 14, 2019
An update on immunotherapy options for urothelial cancerBurak Bilgin, Mehmet A N Sendur, Mutlu Hizal, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Cornea|May 3, 2013
Reply: To PMID 22790186Mustafa Ünal, Osman Sevki Arslan, Burak Bilgin
Optometry and Vision Science : Official Publication of the American Academy of Optometry|March 13, 2013
Treatment of peripheral pigment epithelium iris cyst with SLT laserMete Güler, Burak Bilgin, Ali Hakim Reyhan
European Journal of Ophthalmology|November 21, 2009
Toxic anterior segment syndrome after uncomplicated cataract surgeryN Demet Ozcelik, Kadir Eltutar, Burak Bilgin
Arquivos Brasileiros De Oftalmologia|June 8, 2017
Comparison of optical coherence tomographic findings between Behcet disease patients with and without ocular involvement and healthy subjectsAyse Sevgi Karadag, Burak Bilgin, Merih Banu Soylu
Future Oncology (London, England)|November 25, 2024
What is the ideal treatment for advanced non-small-cell lung cancer with PD-L1 level ≥50%? Is mono immunotherapy enough?Burak Bilgin, Sebnem Yucel, Mehmet Ali Nahit Sendur, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|October 20, 2010
Conversion to deep anterior lamellar keratoplasty (DALK): learning curve with big-bubble techniqueMustafa Unal, Burak Bilgin, Iclal Yucel, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 3, 2017
Negative CDX2 expression can be an important predictive and prognostic biomarker in stage II colon cancerBurak Bilgin, Mehmet A Sendur, Muhammed B Akinci, et al.
Korean Journal of Ophthalmology : KJO|June 2, 2015
Assessment of patient pain experience during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injectionMete Güler, Burak Bilgin, Musa Çapkın, et al.
Strabismus|April 18, 2014
The effects of mild-to-severe retinopathy of prematurity on the development of refractive errors and strabismusHuseyin Gursoy, Hikmet Basmak, Burak Bilgin, et al.
Expert Opinion on Biological Therapy|September 14, 2019
An update on immunotherapy options for urothelial cancerBurak Bilgin, Mehmet A N Sendur, Mutlu Hizal, et al.
Pageof 10